BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6197886)

  • 1. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies.
    Debus E; Moll R; Franke WW; Weber K; Osborn M
    Am J Pathol; 1984 Jan; 114(1):121-30. PubMed ID: 6197886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors.
    van Muijen GN; Ruiter DJ; Ponec M; Huiskens-van der ; Mey C; Warnaar SO
    Am J Pathol; 1984 Jan; 114(1):9-17. PubMed ID: 6197887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by a monoclonal and a polyclonal antibody.
    Ramaekers F; Huysmans A; Moesker O; Schaart G; Herman C; Vooijs P
    Lab Invest; 1985 Jan; 52(1):31-8. PubMed ID: 2578201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratins of normal epithelia and some neoplasms of the female genital tract.
    Moll R; Levy R; Czernobilsky B; Hohlweg-Majert P; Dallenbach-Hellweg G; Franke WW
    Lab Invest; 1983 Nov; 49(5):599-610. PubMed ID: 6195450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to intermediate filament proteins as molecular markers in clinical tumor pathology. Differentiation of carcinomas by their reaction with different cytokeratin antibodies.
    Krepler R; Denk H; Artlieb U; Fichtinger E; Davidovits A
    Pathol Res Pract; 1982; 175(2-3):212-26. PubMed ID: 6190145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
    Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
    Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel monoclonal antibody to cytokeratin 18 with reactivity toward lung squamous cell carcinomas and adenocarcinomas of various sites.
    Chin NW; Zhang R; Nostro DC; Lanks KW
    Am J Pathol; 1992 May; 140(5):1061-9. PubMed ID: 1374589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.
    Holthöfer H; Miettinen A; Paasivuo R; Lehto VP; Linder E; Alfthan O; Virtanen I
    Lab Invest; 1983 Sep; 49(3):317-26. PubMed ID: 6193332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.
    Ramaekers F; Huysmans A; Moesker O; Kant A; Jap P; Herman C; Vooijs P
    Lab Invest; 1983 Sep; 49(3):353-61. PubMed ID: 6193333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin subtypes in carcinomas of the uterine cervix: implications for histogenesis and differential diagnosis.
    Ivanyi D; Groeneveld E; Van Doornewaard G; Mooi WJ; Hageman PC
    Cancer Res; 1990 Aug; 50(16):5143-52. PubMed ID: 1696167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin and neurofilament in lung carcinomas.
    van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
    Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis of tumors of the head and neck using immunohistologic and electron optic studies].
    Vollrath M; Altmannsberger M; Debus E; Osborn M
    Laryngol Rhinol Otol (Stuttg); 1984 Sep; 63(9):475-82. PubMed ID: 6208450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody recognizing a keratin filament protein in a subset of transitional and glandular epithelia.
    Nadakavukaren KK; Summerhayes IC; Salcedo BF; Rheinwald JG; Chen LB
    Differentiation; 1984; 27(3):209-20. PubMed ID: 6209187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
    Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
    Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of human pulmonary carcinomas using monoclonal antibody 44-3A6.
    Lee I; Radosevich JA; Ma YX; Combs SG; Rosen ST; Gould VE
    Cancer Res; 1985 Nov; 45(11 Pt 2):5813-7. PubMed ID: 2414000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.